Overview of Breast Cancer Therapy - PubMed
Review
Overview of Breast Cancer Therapy
Tracy-Ann Moo et al. PET Clin. 2018 Jul.
Abstract
Breast cancer treatment is multidisciplinary. Most women with early stage breast cancer are candidates for breast-conserving surgery with radiotherapy or mastectomy. The risk of local recurrence and the chance of survival does not differ with these approaches. Sentinel node biopsy is used for axillary staging, and individualized approaches are minimizing the need for axillary dissection in women with positive sentinel nodes. Adjuvant systemic therapy is used in most women based on proven survival benefit, and molecular profiling to individualize treatment based on risk is now a clinical reality for patients with hormone receptor-positive cancers.
Keywords: Adjuvant therapy; Breast cancer surveillance; Breast cancer therapy; Breast-conserving therapy; Endocrine therapy; Local therapy; Mastectomy; Neoadjuvant chemotherapy.
Copyright © 2018 Elsevier Inc. All rights reserved.
Figures

SLNB, sentinel lymph node biopsy; BCT, breast-conserving therapy; ALND, axillary lymph node dissection; XRT, breast radiation; SLN, sentinel lymph node; PMRT, postmastectomy radiation therapy

RS: recurrence score

RS: recurrence score
Similar articles
-
Treatment of breast cancer in countries with limited resources.
Carlson RW, Anderson BO, Chopra R, Eniu AE, Jakesz R, Love RR, Masetti R, Schwartsmann G; Global Summit Treatment Panel. Carlson RW, et al. Breast J. 2003 May-Jun;9 Suppl 2:S67-74. doi: 10.1046/j.1524-4741.9.s2.6.x. Breast J. 2003. PMID: 12713499
-
Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D, Holloway C, Shelley W, Down N, Robinson P, Sinclair S, Mirsky D; Breast Cancer Disease Site Group of Cancer Care; Ontario's Program in Evidence-Based Care. McCready D, et al. Can J Surg. 2005 Jun;48(3):185-94. Can J Surg. 2005. PMID: 16013621 Free PMC article.
-
Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G, Di Leone A, Natale M, Sanchez MA, Masett R. Franceschini G, et al. Ann Ital Chir. 2018;89:290. Ann Ital Chir. 2018. PMID: 30352955
-
[3rd Hungarian Breast Cancer Consensus Conference - Radiotherapy Guidelines].
Polgár C, Kahán Z, Csejtei A, Gábor G, Landherr L, Mangel L, Mayer Á, Fodor J. Polgár C, et al. Magy Onkol. 2016 Sep;60(3):229-39. Epub 2016 Jun 15. Magy Onkol. 2016. PMID: 27579722 Hungarian.
-
Axillary node interventions in breast cancer: a systematic review.
Rao R, Euhus D, Mayo HG, Balch C. Rao R, et al. JAMA. 2013 Oct 2;310(13):1385-94. doi: 10.1001/jama.2013.277804. JAMA. 2013. PMID: 24084924 Review.
Cited by
-
Glabridin induces paraptosis-like cell death via ER stress in breast cancer cells.
Cui X, Cui M. Cui X, et al. Heliyon. 2022 Sep 14;8(9):e10607. doi: 10.1016/j.heliyon.2022.e10607. eCollection 2022 Sep. Heliyon. 2022. PMID: 36158101 Free PMC article.
-
A Review of the Advancements in Targeted Therapies for Breast Cancer.
Jallah JK, Dweh TJ, Anjankar A, Palma O. Jallah JK, et al. Cureus. 2023 Oct 28;15(10):e47847. doi: 10.7759/cureus.47847. eCollection 2023 Oct. Cureus. 2023. PMID: 38022130 Free PMC article. Review.
-
Banerjee SM, Acedo P, El Sheikh S, Harati R, Meecham A, Williams NR, Gerard G, Keshtgar MRS, MacRobert AJ, Hamoudi R. Banerjee SM, et al. Front Immunol. 2023 Nov 7;14:1188087. doi: 10.3389/fimmu.2023.1188087. eCollection 2023. Front Immunol. 2023. PMID: 38022682 Free PMC article.
-
Prognostic model construction and target identification of Si-Wu-Tang against breast cancer.
Zhang Z, Zhang Z, Song J, Wu W, Chen Y, Li J, Wang Y, Zhao P. Zhang Z, et al. Heliyon. 2023 Oct 12;9(10):e20709. doi: 10.1016/j.heliyon.2023.e20709. eCollection 2023 Oct. Heliyon. 2023. PMID: 37876445 Free PMC article.
-
Wei M, Bai J, Shen X, Lou K, Gao Y, Lv R, Wang P, Liu X, Zhang G. Wei M, et al. ACS Nano. 2023 Jun 27;17(12):11345-11361. doi: 10.1021/acsnano.3c00350. Epub 2023 Jun 5. ACS Nano. 2023. PMID: 37272787 Free PMC article.
References
-
- Hortobagyi GN, Buzdar AU. Management of locally advanced breast cancer. Am J Clin Oncol. 1988;11(5):597–601. - PubMed
-
- Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41. - PubMed
-
- Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32. - PubMed
-
- Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003;98(4):697–702. - PubMed
-
- Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19(6):1688–97. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical